Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004)
- PMID: 22945286
- PMCID: PMC3572861
- DOI: 10.1038/ajg.2012.298
Surgery in a population-based cohort of Crohn's disease from Olmsted County, Minnesota (1970-2004)
Abstract
Objectives: We sought to estimate the need for surgery in an American population-based cohort of Crohn's disease.
Methods: The medical records of 310 incident cases of Crohn's disease from Olmsted County, Minnesota, diagnosed between 1970 and 2004, were reviewed through March 2009. Cumulative incidence was estimated using the Kaplan-Meier method, and associations between baseline factors and time to first event were assessed using proportional hazards regression and expressed as hazards ratios (HRs) with 95% confidence intervals.
Results: Median follow-up per patient was 12 years. One hundred and fifty-two patients underwent at least 1 major abdominal surgery, 65 had at least 2 surgeries, and 32 had at least 3 surgeries. The cumulative probability of major abdominal surgery was 38, 48, and 58% at 5, 10, and 20 years after diagnosis, respectively. Baseline factors significantly associated with time to major abdominal surgery were: ileocolonic (HR, 3.3), small bowel (HR, 3.4), and upper gastrointestinal (HR, 4.0) extent, relative to colonic alone; current cigarette smoking (HR, 1.7), male gender (HR, 1.6), penetrating disease behavior (HR, 2.7), and early corticosteroid use (HR=1.6). Major abdominal surgery rates remained stable, with 5-year cumulative probabilities in 1970-1974 and 2000-2004 of 37.5 and 35.1%, respectively.
Conclusions: The cumulative probability of major abdominal surgery in this population-based cohort of Crohn's disease approached 60% after 20 years of disease, and many patients required second or third surgeries. Non-colonic disease extent, current smoking, male gender, penetrating disease behavior, and early steroid use were significantly associated with major abdominal surgery.
Conflict of interest statement
Figures




Similar articles
-
Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.Gastroenterology. 2010 Oct;139(4):1147-55. doi: 10.1053/j.gastro.2010.06.070. Epub 2010 Jul 14. Gastroenterology. 2010. PMID: 20637205 Free PMC article.
-
Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.Dis Colon Rectum. 2011 Sep;54(9):1147-54. doi: 10.1097/DCR.0b013e318222ddc3. Dis Colon Rectum. 2011. PMID: 21825896
-
Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis.Dis Colon Rectum. 2021 Feb 1;64(2):217-224. doi: 10.1097/DCR.0000000000001721. Dis Colon Rectum. 2021. PMID: 33315714
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
-
A comprehensive review and update on Crohn's disease.Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18. Dis Mon. 2018. PMID: 28826742 Review.
Cited by
-
Early Initiation of Adalimumab Significantly Diminishes Postoperative Crohn's Disease Endoscopic Recurrence and Is Superior to 6-Mercaptopurine Therapy: An Open-Label, Randomized Controlled Study.J Clin Med. 2023 Dec 10;12(24):7600. doi: 10.3390/jcm12247600. J Clin Med. 2023. PMID: 38137669 Free PMC article.
-
Predicting diagnostic biomarkers associated with immune infiltration in Crohn's disease based on machine learning and bioinformatics.Eur J Med Res. 2023 Jul 26;28(1):255. doi: 10.1186/s40001-023-01200-9. Eur J Med Res. 2023. PMID: 37496049 Free PMC article.
-
Risk factors for postoperative recurrence of Crohn's disease.Middle East J Dig Dis. 2012 Oct;4(4):199-205. Middle East J Dig Dis. 2012. PMID: 24829657 Free PMC article.
-
Kono-S anastomosis in Crohn's disease: initial experience in pediatric patients.Pediatr Surg Int. 2024 Mar 5;40(1):67. doi: 10.1007/s00383-024-05648-6. Pediatr Surg Int. 2024. PMID: 38438752
-
Impact of preoperative use of biologics on 30-day surgical morbidity and mortality in patients with Crohn's disease undergoing ileocolectomy: National Surgical Quality Improvement Program database analysis.Updates Surg. 2025 May 15. doi: 10.1007/s13304-025-02238-6. Online ahead of print. Updates Surg. 2025. PMID: 40372650
References
-
- Peyrin-Biroulet L, Loftus EV, Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn’s disease in population-based cohorts. Am J Gastroenterol. 2010;105:289–97. - PubMed
-
- Bougen G, Peyrin-Biroulet L. Surgery for Adult Crohn’s Disease: What is the Actual Risk? Gut. 2011;60:1178–81. - PubMed
-
- Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of patients with Crohn’s disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology. 2011;141:90–7. - PubMed
-
- Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn’s disease. Gastroenterology. 1993;105:1716–23. - PubMed
-
- Solberg IC, Vatn MH, Hoie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I. Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases